Klothilda Lim

3.0k total citations · 1 hit paper
7 papers, 642 citations indexed

About

Klothilda Lim is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Klothilda Lim has authored 7 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Klothilda Lim's work include Cancer Immunotherapy and Biomarkers (2 papers), Protein Degradation and Inhibitors (2 papers) and Down syndrome and intellectual disability research (1 paper). Klothilda Lim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Protein Degradation and Inhibitors (2 papers) and Down syndrome and intellectual disability research (1 paper). Klothilda Lim collaborates with scholars based in United States, Germany and Japan. Klothilda Lim's co-authors include Henry W. Long, Xintao Qiu, Myles Brown, Deng Pan, Aya Kobayashi, Lucas Ferrari de Andrade, Guo‐Cheng Yuan, John G. Doench, Rong En Tay and Adrienne Luoma and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Cancer Research.

In The Last Decade

Klothilda Lim

6 papers receiving 632 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

2018 567 citations Deng Pan, Aya Kobayashi et al. Science profile →

Peers

Countries citing papers authored by Klothilda Lim

Since Specialization

Citations

This map shows the geographic impact of Klothilda Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klothilda Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klothilda Lim more than expected).

Fields of papers citing papers by Klothilda Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klothilda Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klothilda Lim. The network helps show where Klothilda Lim may publish in the future.

Co-authorship network of co-authors of Klothilda Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Klothilda Lim. A scholar is included among the top collaborators of Klothilda Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klothilda Lim. Klothilda Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Cell-free DNA as a complementary marker of therapeutic futility in adenoid cystic carcinoma 2025 ·Oral Oncology ·(unknown), Klothilda Lim, (unknown), Julia Frede, (unknown), (unknown), Glenn J. Hanna, (unknown), Jens G. Lohr	0
2	Cancer–stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies 2024 ·Proceedings of the National Academy of Sciences ·Marie-Anne Goyette, Laura E. Stevens, (unknown), Marco Seehawer, Jun Nishida, Zheqi Li, (unknown), Rong Li, Xintao Qiu, (unknown), Stephanie Zhao, Klothilda Lim, Gabrielle S. Tender, Jason J. Northey, Nicholas M. Riley, Henry W. Long, Carolyn R. Bertozzi, Valerie M. Weaver, Kornélia Polyák	15
3	Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer 2023 ·Molecular Cancer Therapeutics ·Maša Alečković, Zheqi Li, (unknown), Xintao Qiu, (unknown), Pierre Foidart, (unknown), (unknown), Shaokun Shu, Nikolas Kesten, Rong Li, Klothilda Lim, Ana C. Garrido-Castro, Jennifer L. Guerriero, Jun Qi, Henry W. Long, Kornélia Polyák	6
4	Abstract P108: In vivo CRISPR screens identify E3 ligase COP1 as a modulator of macrophage infiltration and cancer immunotherapy target 2021 ·Molecular Cancer Therapeutics ·Xiaoqing Wang, Collin Tokheim, Shengqing Gu, Binbin Wang, Qin Tang, Yihao Li, Nicole Traugh, Zexian Zeng, Yi Zhang, Boning Zhang, Jingxin Fu, Tengfei Xiao, Wei Li, Clifford A. Meyer, Peng Jiang, Paloma Cejas, Klothilda Lim, Henry W. Long, Myles Brown, X. Shirley Liu	1
5	ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer 2020 ·Cancer Research ·Neel Shah, Nikolas Kesten, Alba Font‐Tello, (unknown), Raga Vadhi, Klothilda Lim, Mark R. Flory, Paloma Cejas, Hisham Mohammed, Henry W. Long, Myles Brown	11
6	A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing breakdown → 2018 ·Science ·Deng Pan, Aya Kobayashi, Peng Jiang, Lucas Ferrari de Andrade, Rong En Tay, Adrienne Luoma, Daphne Tsoucas, Xintao Qiu, Klothilda Lim, Prakash K. Rao, Henry W. Long, Guo‐Cheng Yuan, John G. Doench, Myles Brown, X. Shirley Liu, Kai W. Wucherpfennig	567
7	Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression 2018 ·Cell Reports ·Cody T. Mowery, Jaime M. Reyes, Lucía Cabal‐Hierro, (unknown), Kristen L. Karlin, Jarey H. Wang, Robert Kimmerling, Paloma Cejas, Klothilda Lim, Hubo Li, Takashi Furusawa, Henry W. Long, David Pellman, Bjoern Chapuy, Michael Bustin, Scott R. Manalis, Thomas F. Westbrook, Charles Y. Lin, Andrew A. Lane	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact